Filing Details
- Accession Number:
- 0001209191-12-003501
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-01-12 16:52:38
- Reporting Period:
- 2012-01-12
- Filing Date:
- 2012-01-12
- Accepted Time:
- 2012-01-12 16:52:38
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1429260 | Coronado Biosciences Inc | CNDO | Pharmaceutical Preparations (2834) | 205157386 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1303479 | D Noah Beerman | C/O Coronado Biosciences, Inc. 15 New England Executive Park Burlington MA 01803 | See Remarks | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, Par Value $0.001 | Acquisiton | 2012-01-12 | 5,000 | $4.99 | 5,000 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- Represents the weighted average purchase price for the reported transactions. The range of prices for such transactions was $4.970 to $4.999. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.